TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,120,623 | +7851.8% | 689,236 | +3687.0% | 0.05% | +5200.0% |
| Q4 2022 | $215,306 | +11.6% | 18,200 | -44.1% | 0.00% | 0.0% |
| Q3 2022 | $193,000 | -61.4% | 32,547 | -72.3% | 0.00% | -50.0% |
| Q2 2022 | $500,000 | -77.6% | 117,698 | +75.2% | 0.00% | -75.0% |
| Q3 2021 | $2,236,000 | -35.3% | 67,196 | -24.6% | 0.01% | -33.3% |
| Q2 2021 | $3,457,000 | -30.0% | 89,123 | -13.0% | 0.01% | -45.5% |
| Q1 2021 | $4,938,000 | -53.8% | 102,455 | -50.1% | 0.02% | -53.2% |
| Q4 2020 | $10,687,000 | +90.1% | 205,448 | -2.2% | 0.05% | +113.6% |
| Q3 2020 | $5,622,000 | -38.7% | 210,084 | -55.4% | 0.02% | -52.2% |
| Q2 2020 | $9,177,000 | +2470.6% | 471,089 | +641.5% | 0.05% | +4500.0% |
| Q3 2019 | $357,000 | -72.3% | 63,533 | -57.4% | 0.00% | -80.0% |
| Q2 2019 | $1,290,000 | -15.4% | 149,236 | -21.3% | 0.01% | -16.7% |
| Q1 2019 | $1,525,000 | +44.5% | 189,736 | +136.4% | 0.01% | +50.0% |
| Q2 2018 | $1,055,000 | – | 80,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |